Elyse AI

Company Brief

ELYSE AI: THE $40B MARKET OPPORTUNITY

Transform Elysium Health into the AI-Powered Longevity Platform Leader

See Mobile App Prototype →Visit Elyse AI →
Elyse AI Mobile App Screenshot

Executive Summary

The Perfect Storm: Three Market Forces Converging

    AI Wellness

    $7.80B → $30.56B · 20.5% CAGR

    Longevity Supplements

    $4.52B → $9.79B · 8.03% CAGR

    Personalized Health

    Users want science over style.

Competitive Intelligence

Why Now? Competitors Are Vulnerable

CompanyRevenueCritical WeaknessOur Advantage
Cymbiotika$50M+Poor customer service, subscription complaintsScientific credibility + superior experience
Tru Niagen$100M+Price sensitivity, single ingredientCombination formulations, optimal pricing
Hone Health$50M+Limited to hormonesFull longevity spectrum opportunity

The Gap: No competitor combines Nobel Prize scientific authority with AI-powered personalization.

Mobile App Imperative

Accelerate supplement purchases and AI adoption

A mobile-first experience would convert, retain, and scale more users.

Why mobile drives subscriptions

  • Push notifications reactivate users at intent moments
  • One-tap trials and native payments simplify conversion
  • Daily streaks and habit loops increase LTV and retention
  • Native sensors (camera, HealthKit/Google Fit) enable personalization
  • Micro-sessions increase engagement frequency
2–3x
Activation uplift
+20–30%
Trial → paid
−15–25%
Churn

External proof: Cal AI

Cal AI’s mobile-first approach demonstrates strong subscription potential for AI companions. See business metrics and traction on GetLatka.

$34M
2025 revenue
20–30%
Paid conversion
$2M+
MRR (Jan 2025)
4M+
Downloads (Jan 2025)
  • Mobile-native onboarding reduces friction vs. web
  • Recurring interactions via notifications and widgets
  • Higher ARPU through in-app add-ons and upgrades

Mobile-first experience

  • De-risk: ship v1 mobile app for Elysium Health and Elyse AI
  • Monetize: native trials, annual subscriptions, bundles
  • Differentiate: clinically backed personalization loop

Financial Projections & ROI

The Numbers: Conservative Scenarios

Current State
Annual Revenue$30M
Per Employee$600K
Year 1 (Conservative)
Elyse AI subscribers25,000
ARPU (current pricing)$15/mo
Additional Revenue$375K
ROI300% in 12 months
Year 3 (Market Capture)
AI-powered subscribers75,000
Elyse updated pricing$20/mo
Total Revenue Impact$1.5M
ROI600% over 3 years
Key Metric
Premium pricing 33% above current pricing

Conservative projections show 300% ROI within 14 months, scaling to 600% ROI over 3 years, with pricing at $20/mo vs $15/mo.

Executive Decision

Elysium Health could lead the AI health transformation

300%
ROI in 14 months
10x+
Valuation potential
33%
Premium pricing power
See Mobile App Prototype →Visit Elyse AI →

The window is open now. In 18 months, the market could be crowded.

Sources